1 |
Campochiaro PA. Ocular neovascularization[J]. J Mol Med (Berl), 2013, 91(3): 311-321.
|
2 |
Li X, Xu G, Wang Y, et al. Safety and efficacy of conbercept in neovascular age-related macular degeneration. Results from a 12-month randomized phase 2 study: AURORA study[J]. Ophthalmology, 2014, 121(9): 1740-1747.
|
3 |
Sivaprasad S, Prevost AT, Vasconcelos JC, et al. Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial[J]. Lancet, 2017, 389(10085): 2193-2203.
|
4 |
Sisk RA, Patel YP, Foster RE, et al. Erosive retinopathy and retinal detachment from depot intravitreal triamcinolone acetonide injection at the end of pars plana vitrectomy[J]. Ophthalmic Surg Lasers Imaging Retin, 2019, 50(10): 613-619.
|
5 |
Gross JG, Glassman AR, Jampol LM, et al. Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial[J]. JAMA, 2015, 314(20): 2137-2146.
|
6 |
Chen C, Liu K, Xu Y, et al. Anti-angiogenesis through noninvasive to minimally invasive intraocular delivery of the peptide CC12 identified by in vivo-directed evolution[J]. Biomaterials, 2017, 112: 218-233.
|
7 |
Li J, Cheng T, Tian Q, et al. A more efficient ocular delivery system of triamcinolone acetonide as eye drop to the posterior segment of the eye[J]. Drug Deliv, 2019, 26(1): 188-198.
|
8 |
Jiang K, Hu Y, Gao X, et al. Octopus-like flexible vector for noninvasive intraocular delivery of short interfering nucleic acids[J]. Nano Lett, 2019, 19(9): 6410-6417.
|
9 |
Yang X, Wang L, Li L, et al. A novel dendrimer-based complex co-modified with cyclic RGD hexapeptide and penetratin for noninvasive targeting and penetration of the ocular posterior segment[J]. Drug Deliv, 2019, 26(1): 989-1001.
|
10 |
Dos Santos Rodrigues B, Kanekiyo T, Singh J. ApoE-2 brain-targeted gene therapy through transferrin and penetratin tagged liposomal nanoparticles[J]. Pharm Res, 2019, 36(11): 161.
|
11 |
Shuai Q, Cai Y, Zhao G, et al. Cell-penetrating peptide modified PEG-PLA micelles for efficient PTX delivery[J]. Int J Mol Sci, 2020, 21(5): 1856.
|
12 |
de Cogan F, Hill LJ, Lynch A, et al. Topical delivery of anti-VEGF drugs to the ocular posterior segment using cell-penetrating peptides[J]. Invest Ophthalmol Vis Sci, 2017, 58(5): 2578-2590.
|
13 |
Liu C, Tai LY, Zhang WJ, et al. Penetratin, a potentially powerful absorption enhancer for noninvasive intraocular drug delivery[J]. Mol Pharm, 2014, 11(4): 1218-1227.
|
14 |
Cheng T, Li J, Cheng Y, et al. Triamcinolone acetonide-chitosan coated liposomes efficiently treated retinal edema as eye drops[J]. Exp Eye Res, 2019, 188: 107805.
|
15 |
Lai S, Wei Y, Wu Q, et al. Liposomes for effective drug delivery to the ocular posterior chamber[J]. J Nanobiotechnology, 2019, 17(1): 64.
|
16 |
Zhang Q, Tang J, Fu L, et al. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system[J]. Biomaterials, 2013, 34(32): 7980-7993.
|
17 |
Liu Y, Lu Z, Mei L, et al. Tandem peptide based on structural modification of poly-arginine for enhancing tumor targeting efficiency and therapeutic effect[J]. ACS Appl Mater Interfaces, 2017, 9(3): 2083-2092.
|
18 |
Tai LY, Liu C, Jiang K, et al. A novel penetratin-modified complex for noninvasive intraocular delivery of antisense oligonucleotides[J]. Int J Pharm, 2017, 529(1/2): 347-356.
|
19 |
Eriksen AZ, Brewer J, Andresen TL, et al. The diffusion dynamics of PEGylated liposomes in the intact vitreous of the ex vivo porcine eye: a fluorescence correlation spectroscopy and biodistribution study[J]. Int J Pharm, 2017, 522(1-2): 90-97.
|
20 |
Garbuzenko O, Barenholz Y, Priev A. Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer[J]. Chem Phys Lipids, 2005, 135(2): 117-129.
|
21 |
Davis BM, Normando EM, Guo L, et al. Topical delivery of avastin to the posterior segment of the eye in vivo using annexin A5-associated liposomes[J]. Small, 2014, 10(8): 1575-1584.
|